Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Effectiveness and Safety of Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
Sponsor: Galderma R&D
Listed as NCT03289052, this NA trial focuses on Midface Volume Deficit and remains completed. Sponsored by Galderma R&D, it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2023 — Jun 2023 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Sep 2022 — Dec 2022 [monthly]
Completed NA
-
Apr 2021 — Sep 2022 [monthly]
Completed NA
-
Jan 2021 — Apr 2021 [monthly]
Completed NA
-
Sep 2019 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2018 — Sep 2019 [monthly]
Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Galderma R&D
For direct contact, visit the study record on ClinicalTrials.gov .